Drug Shortage Report for APO-VENLAFAXINE XR
Report ID | 89557 |
Drug Identification Number | 02331691 |
Brand name | APO-VENLAFAXINE XR |
Common or Proper name | VENLAFAXINE XR |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | VENLAFAXINE |
Strength(s) | 75.0MG |
Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
Route of administration | ORAL |
Packaging size | 500 BTL |
ATC code | N06AX |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-07-15 |
Estimated end date | Unknown |
Actual end date | 2019-11-22 |
Shortage status | Resolved |
Updated date | 2019-11-25 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2019-11-25 | French | Compare |
v5 | 2019-11-25 | English | Compare |
v4 | 2019-09-16 | French | Compare |
v3 | 2019-09-16 | English | Compare |
v2 | 2019-07-17 | French | Compare |
v1 | 2019-07-17 | English | Compare |
Showing 1 to 6 of 6